In the initial quarter of 2026, the Pzena Japan Focused Value Composite recorded a modest return of 0.9%, a performance that fell short of both the TOPIX and TOPIX Value benchmarks. This underperformance was significantly influenced by specific sector weaknesses, primarily within industrials, consumer discretionary, and communication services. A key factor in this downturn was Olympus, a prominent medical equipment manufacturer, which emerged as the largest individual detractor. Its negative impact stemmed from quarterly financial outcomes that did not meet expectations and a resurgence of concerns regarding its quality control practices. In contrast, the chemical company Resonac demonstrated positive contributions, driven by robust demand in the back-end semiconductor materials market. Similarly, Fukuoka Financial Group bolstered the composite's performance, buoyed by stronger-than-anticipated earnings reports and increasing market expectations for interest rate adjustments.

Amidst these market dynamics, Pzena Investment Management strategically adjusted its portfolio. The firm initiated new positions in Nakanishi and OMRON, signaling a belief that these companies, currently facing temporary market pressures, possess the potential for long-term profitability recovery through internal self-improvement initiatives. This proactive approach underscores Pzena's investment philosophy of identifying and investing in fundamentally strong businesses that are temporarily undervalued. Concurrently, Pzena opted to divest its holdings in Resonac, INPEX, and Sumitomo Electric, and reduced its stakes in NSK and Daihen. These decisions were primarily driven by re-evaluations of the companies' valuations, indicating a disciplined approach to managing investment risk and optimizing portfolio returns.

Pzena's investment strategy for its Japan Focused Value Composite continues to center on identifying Japanese companies that are not only undervalued but also actively pursuing structural reforms. The firm prioritizes businesses committed to enhancing capital efficiency and maintaining robust balance sheets, while also recognizing the importance of meaningful exposure to cyclical market trends. This dual focus allows Pzena to navigate the complexities of the Japanese market, seeking out opportunities for growth and value creation even amidst challenging market conditions.

Investing wisely involves a careful balance of foresight and adaptability. Pzena's strategic maneuvers within the Japanese market exemplify a dedication to fundamental research and a disciplined approach to investment, ultimately aiming to achieve sustained value for its stakeholders. Such an approach not only seeks financial gains but also fosters confidence in markets by backing companies with strong underlying principles and a clear path to recovery and growth.